Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 2
2007 1
2008 2
2009 6
2010 10
2011 8
2012 7
2013 7
2014 7
2015 19
2016 9
2017 4
2018 5
2019 9
2020 11
2021 11
2022 10
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
Nucleic Acid Delivery.
Lu ZR, Shi GH. Lu ZR, et al. Among authors: shi gh. Pharm Res. 2023 Jan;40(1):1-2. doi: 10.1007/s11095-023-03476-2. Pharm Res. 2023. PMID: 36735107 Free PMC article. No abstract available.
The function and mechanisms of action of circular RNAs in Urologic Cancer.
Zhang ZH, Wang Y, Zhang Y, Zheng SF, Feng T, Tian X, Abudurexiti M, Wang ZD, Zhu WK, Su JQ, Zhang HL, Shi GH, Wang ZL, Cao DL, Ye DW. Zhang ZH, et al. Among authors: shi gh. Mol Cancer. 2023 Mar 25;22(1):61. doi: 10.1186/s12943-023-01766-2. Mol Cancer. 2023. PMID: 36966306 Free PMC article. Review.
A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population.
Qu Y, Feng J, Wu X, Bai L, Xu W, Zhu L, Liu Y, Xu F, Zhang X, Yang G, Lv J, Chen X, Shi GH, Wang HK, Cao DL, Xiang H, Li L, Tan S, Gan HL, Sun MH, Qiu J, Zhang H, Zhao JY, Ye D, Ding C. Qu Y, et al. Among authors: shi gh. Nat Commun. 2022 Apr 19;13(1):2052. doi: 10.1038/s41467-022-29577-x. Nat Commun. 2022. PMID: 35440542 Free PMC article.
Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor.
Zhang H, Bai L, Wu XQ, Tian X, Feng J, Wu X, Shi GH, Pei X, Lyu J, Yang G, Liu Y, Xu W, Anwaier A, Zhu Y, Cao DL, Xu F, Wang Y, Gan HL, Sun MH, Zhao JY, Qu Y, Ye D, Ding C. Zhang H, et al. Among authors: shi gh. Nat Commun. 2023 Jul 17;14(1):4274. doi: 10.1038/s41467-023-39981-6. Nat Commun. 2023. PMID: 37460463 Free PMC article.
Proteogenomic characterization of MiT family translocation renal cell carcinoma.
Qu Y, Wu X, Anwaier A, Feng J, Xu W, Pei X, Zhu Y, Liu Y, Bai L, Yang G, Tian X, Su J, Shi GH, Cao DL, Xu F, Wang Y, Gan HL, Ni S, Sun MH, Zhao JY, Zhang H, Ye D, Ding C. Qu Y, et al. Among authors: shi gh. Nat Commun. 2022 Dec 5;13(1):7494. doi: 10.1038/s41467-022-34460-w. Nat Commun. 2022. PMID: 36470859 Free PMC article.
Hydrodynamic considerations for spring-driven autoinjector design.
Zhong X, Veilleux JC, Shi GH, Collins DS, Vlachos P, Ardekani AM. Zhong X, et al. Among authors: shi gh. Int J Pharm. 2023 Jun 10;640:122975. doi: 10.1016/j.ijpharm.2023.122975. Epub 2023 Apr 26. Int J Pharm. 2023. PMID: 37116602
Subcutaneous Injection Site Pain of Formulation Matrices.
Shi GH, Pisupati K, Parker JG, Corvari VJ, Payne CD, Xu W, Collins DS, De Felippis MR. Shi GH, et al. Pharm Res. 2021 May;38(5):779-793. doi: 10.1007/s11095-021-03047-3. Epub 2021 May 3. Pharm Res. 2021. PMID: 33942212 Clinical Trial.
123 results